Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • nct (2)
Country
  • Argentina (2)
  • Belgium (2)
  • Canada (2)
  • Finland (2)
  • France (2)
  • Germany (2)
  • Hungary (2)
  • Poland (2)
  • Spain (2)
  • Sweden (2)
  • United Kingdom (2)
  • United States (2)
  • Australia (1)
  • Austria (1)
  • Colombia (1)
  • Denmark (1)
  • Egypt (1)
  • Guatemala (1)
  • Iceland (1)
  • India (1)
  • Ireland (1)
  • Israel (1)
  • Italy (1)
  • Korea, Republic of (1)
  • Netherlands (1)
  • Norway (1)
  • Philippines (1)
  • Romania (1)
  • Singapore (1)
  • Switzerland (1)
Source
  • nct (2)
Phase
  • complete (2)

Country: United Kingdom,Argentina,Poland,United States,Canada,Hungary - Promoter: nct
nct Update Il y a 5 ans

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis This study will assess the safety and efficacy of secukinumab compared to placebo and etanercept in patients that have moderate to severe, chronic, plaque-type psoriasis.

  • Country Argentina, Australia, Belgium, Canada, Colombia, Egypt, Finland, France, Germany, Guatemala, Hungary, Iceland, India, Italy, Korea, Republic of, Philippines, Poland, Romania, Singapore, Spain, Sweden, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information
nct Update Il y a 5 ans

A Long-term Safety Study of Infliximab (Remicade) This is a study evaluating the long-term safety of infliximab (Remicade)

  • Country Argentina, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States,
  • organs None
  • Specialty None
Closed trial
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2024 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.